Targeted next-generation sequencing of plasma DNA from cancer patients: factors influencing consistency with tumour DNA and prospective investigation of its utility for diagnosis
Use of circulating tumour DNA (ctDNA) as a liquid biopsy has been proposed for potential identification and monitoring of solid tumours. We investigate a next-generation sequencing approach for mutation detection in ctDNA in two related studies using a targeted panel. The first study was retrospecti...
Main Authors: | Kaisaki, P, Cutts, A, Popitsch, N, Camps, C, Pentony, M, Wilson, G, Page, S, Kaur, K, Vavoulis, D, Henderson, S, Gupta, A, Middleton, M, Karydis, I, Talbot, D, Schuh, A, Taylor, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2016
|
Similar Items
-
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.
by: Pamela J Kaisaki, et al.
Published: (2016-01-01) -
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
by: Hamblin, A, et al.
Published: (2017) -
Monitoring circulating tumour DNA in patients receiving selective internal radiation therapy for liver metastases and intrahepatic cholangiocarcinoma
by: Winter, H, et al.
Published: (2016) -
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
by: Angela Hamblin, et al.
Published: (2017-02-01) -
Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA
by: Cutts, A, et al.
Published: (2017)